Gheorghe‐Andrei Dan

10.4k total citations
71 papers, 536 citations indexed

About

Gheorghe‐Andrei Dan is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Gheorghe‐Andrei Dan has authored 71 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cardiology and Cardiovascular Medicine, 10 papers in Internal Medicine and 9 papers in Economics and Econometrics. Recurrent topics in Gheorghe‐Andrei Dan's work include Atrial Fibrillation Management and Outcomes (40 papers), Cardiac Arrhythmias and Treatments (24 papers) and Cardiac electrophysiology and arrhythmias (19 papers). Gheorghe‐Andrei Dan is often cited by papers focused on Atrial Fibrillation Management and Outcomes (40 papers), Cardiac Arrhythmias and Treatments (24 papers) and Cardiac electrophysiology and arrhythmias (19 papers). Gheorghe‐Andrei Dan collaborates with scholars based in Romania, United Kingdom and Serbia. Gheorghe‐Andrei Dan's co-authors include Tatjana Potpara, Gregory Y.H. Lip, Dobromir Dobrev, Caterina Delcea, A Buzea, Marco Vitolo, Francisco Marı́n, Giuseppe Boriani, Marco Proietti and Konstantinos Iliodromitis and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and European Heart Journal.

In The Last Decade

Gheorghe‐Andrei Dan

65 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gheorghe‐Andrei Dan Romania 14 438 55 55 47 46 71 536
Do Young Kim South Korea 13 379 0.9× 75 1.4× 45 0.8× 81 1.7× 44 1.0× 26 497
Xing‐hui Shao China 12 378 0.9× 41 0.7× 63 1.1× 53 1.1× 77 1.7× 54 480
Qinmei Xiong China 15 473 1.1× 41 0.7× 58 1.1× 29 0.6× 72 1.6× 33 607
Ki Yung Boo South Korea 10 329 0.8× 29 0.5× 44 0.8× 46 1.0× 44 1.0× 27 411
Federica Agnello Italy 12 247 0.6× 158 2.9× 36 0.7× 73 1.6× 48 1.0× 27 422
Akash Batta India 11 210 0.5× 73 1.3× 62 1.1× 36 0.8× 19 0.4× 66 349
Dritan Poçi Sweden 11 673 1.5× 57 1.0× 65 1.2× 77 1.6× 64 1.4× 23 720
Sharan Prakash Sharma United States 14 258 0.6× 74 1.3× 15 0.3× 44 0.9× 32 0.7× 41 449
Osman Beton Türkiye 11 174 0.4× 69 1.3× 38 0.7× 38 0.8× 51 1.1× 45 303
Mehmet Ballı Türkiye 11 256 0.6× 98 1.8× 50 0.9× 83 1.8× 54 1.2× 38 381

Countries citing papers authored by Gheorghe‐Andrei Dan

Since Specialization
Citations

This map shows the geographic impact of Gheorghe‐Andrei Dan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gheorghe‐Andrei Dan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gheorghe‐Andrei Dan more than expected).

Fields of papers citing papers by Gheorghe‐Andrei Dan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gheorghe‐Andrei Dan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gheorghe‐Andrei Dan. The network helps show where Gheorghe‐Andrei Dan may publish in the future.

Co-authorship network of co-authors of Gheorghe‐Andrei Dan

This figure shows the co-authorship network connecting the top 25 collaborators of Gheorghe‐Andrei Dan. A scholar is included among the top collaborators of Gheorghe‐Andrei Dan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gheorghe‐Andrei Dan. Gheorghe‐Andrei Dan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boriani, Giuseppe, Davide Antonio Mei, Niccolò Bonini, et al.. (2025). Chronic kidney disease classification according to different formulas and impact on adverse outcomes in patients with atrial fibrillation: A report from a prospective observational European registry. European Journal of Internal Medicine. 136. 86–94. 5 indexed citations
2.
Komiyama, Maki, Moritake Iguchi, Hiromichi Wada, et al.. (2024). What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?. European Cardiology Review. 19. e10–e10. 1 indexed citations
3.
4.
Toennis, Tobias, Emanuele Bertaglia, Axel Brandes, et al.. (2023). The influence of atrial high-rate episodes on stroke and cardiovascular death: an update. EP Europace. 25(7). 23 indexed citations
5.
Vitolo, Marco, Marco Proietti, Jacopo Francesco Imberti, et al.. (2023). Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients. Journal of Clinical Medicine. 12(3). 768–768. 10 indexed citations
6.
Potpara, Tatjana, Dominick J. Angiolillo, Behnood Bikdeli, et al.. (2023). Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19. CHEST Journal. 164(6). 1531–1550. 1 indexed citations
7.
Petre, Alexandru Eugen, et al.. (2023). The portrait of a stranger: the hypereosinophilic syndrome with cardiac involvement. Romanian Journal of Internal Medicine. 61(4). 222–227.
8.
Buzea, A, et al.. (2022). Sarcopenia assessed by total psoas index – is it correlated with post-operative complications in all digestive cancers?. Medicine and Pharmacy Reports. 96(3). 274–282. 1 indexed citations
9.
10.
Kozieł, Monika, Stefan Simović, Nikola Pavlović, et al.. (2020). Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey. Annals of Medicine. 53(1). 17–25. 17 indexed citations
11.
Lane, Deirdre A., Gheorghe‐Andrei Dan, Wolfram Doehner, et al.. (2020). Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey. EP Europace. 23(5). 806–814. 7 indexed citations
12.
Bertaglia, Emanuele, Benjamin Blank, Carina Blomström‐Lundqvist, et al.. (2019). Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence. EP Europace. 21(10). 1459–1467. 44 indexed citations
13.
Kozieł, Monika, Stefan Simović, Nikola Pavlović, et al.. (2019). Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey. IJC Heart & Vasculature. 26. 100461–100461. 5 indexed citations
14.
Dan, Gheorghe‐Andrei & Dobromir Dobrev. (2018). Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging. IJC Heart & Vasculature. 21. 11–15. 25 indexed citations
15.
16.
Dan, Gheorghe‐Andrei, et al.. (2016). Role of stromal cell-derived factor 1α pathway in bone metastatic prostate cancer. Journal of Biomedical Research. 30(3). 181–181. 12 indexed citations
17.
Dima, Alina, Ciprian Jurcuț, A. Balanescu, et al.. (2015). Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients. 53(4). 321–328. 6 indexed citations
18.
Huber, Kurt, Stuart J. Connolly, A Kher, et al.. (2013). Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation. International Journal of Clinical Practice. 67(6). 516–526. 15 indexed citations
19.
Mentz, Robert J., Juan‐Carlos Kaski, Gheorghe‐Andrei Dan, et al.. (2012). Implications of geographical variation on clinical outcomes of cardiovascular trials. American Heart Journal. 164(3). 303–312. 31 indexed citations
20.
Popović, Zoran, Richard A. Grimm, Ali Ahmad, et al.. (2007). Longitudinal rotation: an unrecognised motion pattern in patients with dilated cardiomyopathy. Heart. 94(3). e11–e11. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Do Young Kim Breakdown of academic impact, for papers by Xing‐hui Shao Breakdown of academic impact, for papers by Qinmei Xiong Breakdown of academic impact, for papers by Ki Yung Boo Breakdown of academic impact, for papers by Federica Agnello Breakdown of academic impact, for papers by Akash Batta Breakdown of academic impact, for papers by Dritan Poçi Breakdown of academic impact, for papers by Sharan Prakash Sharma Breakdown of academic impact, for papers by Osman Beton Breakdown of academic impact, for papers by Mehmet Ballı
Rankless by CCL
2026